At Cannatest we provide profiling for the six most prevalent cannabinoids - THC, THCV, CBG, CBC, CBN, and CBD, as well as the acidic levels of the neutral cannabinoids such as THCA. For years now THC has been described as the primary compound in cannabis, but recent research has identified many other important cannabinoids each linked with specific medical effects.
Since the 1980’s, when it was first discovered that humans had cannabinoid receptor cells, lots of research has been done on the different effects and workings of cannabinoids. Today, there are literally hundreds, maybe even thousands of cannabis strain names, each with their own unique balance of cannabinoids and potency. These differences result from breeding and growing conditions, nutrients and of course the genetics of the strain.
When considering cannabis as a medicine it is important to remember that each of us has a unique physiological make up, and each plant, strain, and cannabinoid ratio will therefore effect each of us differently. We recommend seeking advice from a trained medical professional first and then sampling and evaluating tested cannabis strains for your individual response. This will educate you to select the cannabinoid profile, and not the name of a strain, that best suits your medical needs.
Our test results provide a quick visual profile of the potency of these cannabinoids. Below you will find a small sampling of what we know thus far about some of the the more prevalent cannabinoids. Developed by Alpha-CAT in the Netherlands, the poster above represents the cannabinoid fingerprint. Click here to see the Cannabinoid Chemo Chart.
Cannabinoid
Effects, features & Medical Applications
THC
Tetrahydrocannabinol
Brief:
Responsible for the ‘’High’’-effect (psychotropic): it amplifies all sensory functions such as sight, hearing, color sensitivity and increases sexual arousal and a greater sense of well being. Produces strong feelings of euphoria. Sharpens the mind (cerebral) and promotes creativity. Analgesic (pain relieving), sedative, relaxing, energetic, promotes creativity.
Discovery:
1964, Gaoni and Mechoulm, Weizmann Institue Rehovot.
Known Medicinal Benefits:
Anxiolytic – reduces the symptoms of anxiety
Neuroprotective – protects against nerve damage
Antispasmodic – relieves spasms and convulsions
Antiemetic – reduces vomiting and nausea
Analgesic – reduces pain
Appetite Stimulant – encourages eating and appetite
Antioxidant – fights free radicals in the bloodstream
Neuropathic analgesic – reduces pain from nervedamage
Bronchi-dialator -acts similarly to an inhaler to assist asthmatics with breathing
Anti-proliferative anticancer – reduces spread of certain cancers
Anti-inflammatory – reduces inflammation
Neurogenesis – promotes growth of new nerve tissue
Neuroprotectant – protects nerves from damage
THCV
Tetrahydrocannabivarin
Brief:
A psychoactive cannabinoid found along with THC in cannabis, research has shown that, in low doses, THCV will increase the effects of THC (strongly potentiating THC, provoking a heavy, stronger and faster “High”-effect) but in larger doses THCV is believed to oppose the effects of THC. Recent research into THCV has focused on its ability to reduce appetite.
Discovery: 1970, Edward Gil and colleagues, UK
Known medical benefits:
Apetite suppressant
CBD
Cannabidiol
Brief:
CBD works antagonistically in the micromolar range; it has an opposite effect of THC. It reduces the psychoactive effect, or the ‘’high’’ of THC, but in contrast, it will prolong slowly but increasingly this effect strongly. Not psychoactive. Effective against anxiety and stress (sedative). Strong muscle relaxation, especially on the smooth muscle fibers thus reducing muscle spasms.
Discovery:
1940, first isolated by Adams and colleagues, and stereochemically determined in 1963 by Mechoulam and Shvo.
Known Medicinal Benefits:
Anxiolytic – reduces the symptoms of anxiety.
Antiepileptic - reduces seizures and convulsions
Neuroprotective – protects against nerve damage
Vasorelaxant – reduces tension in blood vessel walls
Antispasmodic – relieves spasms and convulsions
Anti-ischemic – reduces risk of artery blockage
Antiemetic – reduces vomiting and nausea
Antibacterial – kills surface bacteria
Antidiabetic – reduces blood sugar levels
Antipsoriatic – reduces effects of psoriasis
Antipsychotic – reduces psychosis including delusions or hallucinations
Analgesic – reduces pain
Bone-stimulant – promotes bone growth
Intestinal anti-prokinetic – reduces contractions in the small intestine
Anti-inflammatory – reduces inflammation
Antiproliferative anticancer – reduces spread of certain cancers
Immunosuppressant – reduces function in immune system
CBN
Cannabinol
Brief:
Mildly psychoactive, sedative, analgesic. CBN is, just like aspirin, a non-narcotic type analgesic, but 3x as strong. CBN is a breakdown product of THC. During storage (aging) CBN will slowly increase as THC deteriorates. CBN is effective at relieving tension headache.
Discovery:
1896, Wood and colleagues in Cambridge, the first natural cannabinoid to be obtained in pure form
Known Medicinal Benefits:
Antispasmodic – relieves spasms and convulsions
Analgesic – reduces pain
Anti-inflammatory – reduces inflammation
Antioxidant – fights free radicals in the bloodstream
CBG
Cannabigerol
Brief:
Sedative, CBG tends to be higher in cannabis species without much THC (hemp varieties) and has hitherto been found only in trace amounts in most marijuana strains. CBG is the precursor form of a few of the other cannabinoids including THC and CBD.While little research has been conducted on CBG, it has been found to have medical properties including acting as a sedative, sleep inducer. Anti-microbial properties make it effective in treating bacterial infections.
Discovery:
1964 Gaoni and Mechoulam
Known Medicinal Benefits:
Antibacterial – kills surface bacteria
Anti-microbial
Antiproliferative – inhibits cell growth
Bone Stimulant – promotes bone growth
CBC
Cannabichromene
Brief:
Non-psychoactive cannabinoid that also potentiates THC. It interacts in an as yet unknown way with THC to make the ‘’high’’ more intense and pronounced. it is also considered a strong sedative and analgesic.
Discovery:
1966 independently reported by Claussen and colleagues as well as Gaoni and Mechoulam.
Known Medicinal Benefits:
Anti-inflammatory – reduces inflammation
Analgesic – reduces pain
Bone Stimulant – promotes bone growth
Antimicrobial – kills bacteria or fungi
Antiproliferative – inhibits cell growth
Vasoconstriction - constricting of the blood vessels
Effective treatment of migraine
THCA
D9-Tetrahydrocannabinolic Acid
Brief:
D9-THC has two acidic analogs: D9-THCA A and D9-THCA Bc. D9-THCA
Discovery:
D9-THCA A, first extracted by Korte and coworkers (1965), was isolated as a pure compound in 1967 by Nishioka’s group. In 1969, Mechoulam and coworkers reported the isolation of D9-THCA B.
Known medical benefits:
Anti-proliferative
Anti-spasmodic
Anti-inflamatory
CBDA
Cannabidiolic Acid
Brief:
The first cannabinoid acidc to be discovered,Together with CBD, CBDA is the main component of glandular hairs (up to 15%). In fresh plant material, 95% of CBD exists as its acid.
Discovery: 1955, Isolated by Krejci and Santavy.
Known Medical Benefits:
Anti-proliferative actions
References
Angelo A. Izzo1,4, Francesca Borrelli1,4, Raffaele Capasso1,4, Vincenzo Di Marzo2,4 and Raphael Mechoulam3. (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.TIPS-730. 13
Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy 2 Institute of Biomolecular Chemistry, National Research Council, Pozzuoli (NA), Italy 3 Department of Medicinal Chemistry and Natural Products, Hebrew University Medical Faculty, Jerusalem, Israel 4 Endocannabinoid Research Group, Italy